PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9768595-9 1998 Pretreatment with IL-3 (1 to 10 ng/mL) markedly enhanced ionomycin (0.1 microg/mL)-mediated AA and LTC4 generation. Ionomycin 57-66 interleukin 3 Homo sapiens 18-22 7629513-2 1995 Ionomycin, but not IgE immune complexes, causes these cells to release serotonin and to express IL-3 and IL-13 mRNA, consistent with their being FC epsilon RI-deficient mast cells. Ionomycin 0-9 interleukin 3 Homo sapiens 96-100 9020523-3 1997 Treatment of the cells with the immunosuppressant CsA at 10(-5) M produced a significant inhibition of ionomycin-induced expression of IL-3, IL-4 and IL-8 mRNA, and at 10(-6) M produced a significant inhibition of induced expression of IL-3 and IL-8 but not IL-4. Ionomycin 103-112 interleukin 3 Homo sapiens 135-139 9020523-3 1997 Treatment of the cells with the immunosuppressant CsA at 10(-5) M produced a significant inhibition of ionomycin-induced expression of IL-3, IL-4 and IL-8 mRNA, and at 10(-6) M produced a significant inhibition of induced expression of IL-3 and IL-8 but not IL-4. Ionomycin 103-112 interleukin 3 Homo sapiens 236-240 9020523-5 1997 Treatment of the cells with the corticosteroid DEX at 10(-5) M but not 10(-6) M significantly reduced the ionomycin-induced expression of IL-3 but not IL-4 or IL-8 mRNA. Ionomycin 106-115 interleukin 3 Homo sapiens 138-142 8625537-9 1996 Similar but transient inhibition of most T-cell products (IL-2, IL-3, IL-4, IL-5, IL-10, TNF-beta and GM-CSF) was noted in the PMA/ionomycin-containing cultures. Ionomycin 131-140 interleukin 3 Homo sapiens 64-68 7751024-3 1995 Stimulation of non-IL-4-treated cells with ionomycin (10 microM) for periods of 30 min to 8 hr induced expression of mRNA encoding IL-3, IL-4 and IL-8 but was without effect on levels of mRNA for tumour necrosis factor (TNF)-alpha or beta-actin. Ionomycin 43-52 interleukin 3 Homo sapiens 131-135 7631148-4 1995 After treatment with the phorbol ester TPA or the calcium ionophore ionomycin expression of several cytokines, i.e. IL-1 beta, IL-3, IL-6, GM-CSF, TNF-beta and PDGF-A, could be detected. Ionomycin 68-77 interleukin 3 Homo sapiens 127-131 7542063-3 1995 IL-4, but not SCF, enhanced ionomycin-induced transcription and secretion of several genes, including the cytokines IL-3, IL-4, granulocyte/macrophage-colony-stimulating factor, IL-8 and the receptor for IL-6 in the human HMC-1 mast cell line. Ionomycin 28-37 interleukin 3 Homo sapiens 116-120 7751024-5 1995 More notably, the IL-4 treatment produced a pronounced elevation of mRNA for IL-3 and IL-8 when the cells were subsequently activated with ionomycin. Ionomycin 139-148 interleukin 3 Homo sapiens 77-81 7751024-7 1995 Quantitation of cDNA by competitive polymerase chain reaction (PCR) revealed that the IL-4 treatment produced a sixfold increase in ionomycin-induced levels of cellular IL-3 mRNA, a fourfold increase in induced IL-8 mRNA and less than a twofold increase in induced IL-4 mRNA. Ionomycin 132-141 interleukin 3 Homo sapiens 169-173 7751024-8 1995 The IL-4 treatment led to a 15- to 20-fold increase in ionomycin-induced secretion of IL-3 product and a doubling of induced IL-8 product. Ionomycin 55-64 interleukin 3 Homo sapiens 86-90 8233727-11 1993 Considering the low proportion of lymphocytes, stimulation with phorbol myristate acetate in combination with ionomycin resulted in considerable production of the following lymphokines: IL-2, IL-3, IL-4, IL-10, interferon-gamma, tumor necrosis factor-alpha. Ionomycin 110-119 interleukin 3 Homo sapiens 192-196 1718740-1 1991 IL-3 dependent mast cell lines produce cytokines in response to Fc receptor cross-linkage or to ionomycin. Ionomycin 96-105 interleukin 3 Homo sapiens 0-4 1875171-4 1991 Moreover, IL-3 and GM-CSF were measurable in ionomycin-stimulated eosinophil supernatants by immunoassay. Ionomycin 45-54 interleukin 3 Homo sapiens 10-14 2556442-4 1989 IL-3 expression could also be induced by costimulation of T cells with both phorbol ester and ionomycin, which are thought to mimic the intracellular effects of T cell receptor-antigen interaction. Ionomycin 94-103 interleukin 3 Homo sapiens 0-4 2676015-5 1989 On stimulation of BMCs with phorbol myristate acetate (PMA) and phytohemagglutinin or PMA and the calcium ionophore ionomycin, approximately 5% expressed GM-CSF mRNA and approximately 1% IL-3 mRNA. Ionomycin 116-125 interleukin 3 Homo sapiens 187-191 2676015-11 1989 Treatment of BMCs with high-dose interleukin-2 (IL-2) for 1 week followed by PMA plus ionomycin resulted in a lymphocyte population in which 50% and 3% of cells expressed GM-CSF and IL-3 mRNA, respectively. Ionomycin 86-95 interleukin 3 Homo sapiens 182-186